PMAIP1 and thyroid cancer, nonmedullary, 2: Therefore, investigating the regulatory relationship between the novel FTC oncogene PMAIP1 and the Wnt pathway during FTC progression opened new avenues for dual-targeted therapy of this malignancy, which holds substantial clinical significance.